Abstract
Melanoma is a more aggressive type of skin cancer, as it has a high metastatic potential. Despite its low incidence, corresponding to 3% of skin neoplasms in Brazil, it has a fatality rate of approximately 75%. Currently, the best therapies for treating melanoma are alternatives, which are currently the fusion treatment of toxic drugs, especially dacarbazine and platinum-derived compounds…